FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136116750> ?p ?o ?g. }

• W3136116750 endingPage "182" @default.
• W3136116750 startingPage "164" @default.
• W3136116750 abstract "Metastatic triple negative breast cancer (TNBC) has an aggressive phenotype with a predilection for visceral organs and brain. Best responses to chemotherapy are predominately in the first line. Recent studies have demonstrated improved progression free survival with the combination of atezolizumab/pembrolizumab and chemotherapy in programmed death-ligand 1 positive metastatic TNBC. However, a recent trial in a similar population showed no benefit for atezoli-zumab and paclitaxel which led to a Food and Drug Administration alert. Two phase III trials (OLYMPIAD and BROCADE3) demonstrated a benefit in progression free survival (PFS) but not overall survival in patients with BRCA-associated metastatic TNBC treated with Olaparib or Talazoparib respectively. For those treated with Talazoparib, the time to deterioration in health related-quality of life was also longer compared to chemotherapy. The BROCADE3 trial demonstrated that the combination of a platinum and veliparib increased PFS in first-line metastatic TNBC but at the cost of increased toxicity. There are no head-to-head comparisons of a poly (adenosine diphosphate-ribose) polymerase inhibitors (PARPi) and platinums. There are unanswered questions regarding the role of PARPi maintenance after platinum therapy as is standard of care in BRCA-associated ovarian cancer. Other areas of therapeutic interest include targeting aberrations in the phosphoinositide 3-kinase pathway, protein kinase B, mammalian target of rapamycin or utilising antibody drug conjugates. This review focusses on recent and emerging therapeutic options in metastatic TNBC. We searched PubMed, clinicaltrials.gov and recent international meetings from American Society of Clinical Oncology, San Antonio Breast Cancer Conference and the European Society of Medical Oncology." @default.
• W3136116750 created "2021-03-29" @default.
• W3136116750 creator A5000454137 @default.
• W3136116750 creator A5076556096 @default.
• W3136116750 creator A5091038578 @default.
• W3136116750 date "2021-03-24" @default.
• W3136116750 modified "2023-10-14" @default.
• W3136116750 title "Overview of recent advances in metastatic triple negative breast cancer" @default.
• W3136116750 cites W1523531555 @default.
• W3136116750 cites W1861588860 @default.
• W3136116750 cites W1949237903 @default.
• W3136116750 cites W1972680809 @default.
• W3136116750 cites W2035077913 @default.
• W3136116750 cites W2074465378 @default.
• W3136116750 cites W2077775719 @default.
• W3136116750 cites W2080325390 @default.
• W3136116750 cites W2096027508 @default.
• W3136116750 cites W2097255042 @default.
• W3136116750 cites W2099335989 @default.
• W3136116750 cites W2100413206 @default.
• W3136116750 cites W2105496345 @default.
• W3136116750 cites W2107587681 @default.
• W3136116750 cites W2111437716 @default.
• W3136116750 cites W2118605519 @default.
• W3136116750 cites W2120431466 @default.
• W3136116750 cites W2120512382 @default.
• W3136116750 cites W2121356187 @default.
• W3136116750 cites W2127152525 @default.
• W3136116750 cites W2133349592 @default.
• W3136116750 cites W2137162822 @default.
• W3136116750 cites W2143459396 @default.
• W3136116750 cites W2150633526 @default.
• W3136116750 cites W2157285286 @default.
• W3136116750 cites W2161770015 @default.
• W3136116750 cites W2163017141 @default.
• W3136116750 cites W2170602872 @default.
• W3136116750 cites W2295085830 @default.
• W3136116750 cites W2340735966 @default.
• W3136116750 cites W2345415641 @default.
• W3136116750 cites W2468483329 @default.
• W3136116750 cites W2593352313 @default.
• W3136116750 cites W2607761262 @default.
• W3136116750 cites W2613712678 @default.
• W3136116750 cites W2621271973 @default.
• W3136116750 cites W2725777854 @default.
• W3136116750 cites W2733049975 @default.
• W3136116750 cites W2743639018 @default.
• W3136116750 cites W2747774814 @default.
• W3136116750 cites W2760931533 @default.
• W3136116750 cites W2763602017 @default.
• W3136116750 cites W2766673799 @default.
• W3136116750 cites W2793490494 @default.
• W3136116750 cites W2795120383 @default.
• W3136116750 cites W2801956643 @default.
• W3136116750 cites W2806003529 @default.
• W3136116750 cites W2806936224 @default.
• W3136116750 cites W2884883038 @default.
• W3136116750 cites W2886477543 @default.
• W3136116750 cites W2889746019 @default.
• W3136116750 cites W2897422388 @default.
• W3136116750 cites W2897523860 @default.
• W3136116750 cites W2900082702 @default.
• W3136116750 cites W2902530914 @default.
• W3136116750 cites W2909799373 @default.
• W3136116750 cites W2915321625 @default.
• W3136116750 cites W2917403028 @default.
• W3136116750 cites W2920349603 @default.
• W3136116750 cites W2930305328 @default.
• W3136116750 cites W2938395656 @default.
• W3136116750 cites W2944913534 @default.
• W3136116750 cites W2946054739 @default.
• W3136116750 cites W2946975407 @default.
• W3136116750 cites W2965681656 @default.
• W3136116750 cites W2972432710 @default.
• W3136116750 cites W2977211443 @default.
• W3136116750 cites W2978854127 @default.
• W3136116750 cites W2979272694 @default.
• W3136116750 cites W2995857279 @default.
• W3136116750 cites W2996630100 @default.
• W3136116750 cites W2996642785 @default.
• W3136116750 cites W2997305322 @default.
• W3136116750 cites W3004453915 @default.
• W3136116750 cites W3005585857 @default.
• W3136116750 cites W3005714839 @default.
• W3136116750 cites W3006930853 @default.
• W3136116750 cites W3013223671 @default.
• W3136116750 cites W3029871260 @default.
• W3136116750 cites W3030206881 @default.
• W3136116750 cites W3031702570 @default.
• W3136116750 cites W3069915980 @default.
• W3136116750 cites W3088810176 @default.
• W3136116750 cites W3093265161 @default.
• W3136116750 cites W3095316560 @default.
• W3136116750 cites W4239051461 @default.
• W3136116750 cites W4242907494 @default.
• W3136116750 cites W4256127173 @default.
• W3136116750 cites W4256518583 @default.
• W3136116750 doi "https://doi.org/10.5306/wjco.v12.i3.164" @default.

• next